KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Royalty Pharma (RPRX) Treasury Shares: 2019-2024

Historic Treasury Shares for Royalty Pharma (RPRX) over the last 6 years, with Dec 2024 value amounting to $2.7 million.

  • Royalty Pharma's Treasury Shares fell 1.73% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 1.73%. This contributed to the annual value of $2.7 million for FY2024, which is 1.26% up from last year.
  • As of FY2024, Royalty Pharma's Treasury Shares stood at $2.7 million, which was up 1.26% from $2.6 million recorded in FY2023.
  • In the past 5 years, Royalty Pharma's Treasury Shares registered a high of $9.8 million during FY2023, and its lowest value of $8.4 million during FY2024.
  • Its 2-year average for Treasury Shares is $9.1 million, with a median of $9.1 million in 2023.
  • As far as peak fluctuations go, Royalty Pharma's Treasury Shares crashed by 45.69% in 2020, and later climbed by 17.18% in 2021.
  • Yearly analysis of 5 years shows Royalty Pharma's Treasury Shares stood at $2.3 million in 2020, then rose by 17.18% to $2.7 million in 2021, then rose by 3.35% to $2.8 million in 2022, then decreased by 6.31% to $2.6 million in 2023, then rose by 1.26% to $2.7 million in 2024.